ERα mediates the cancer-promoting effects of estrogens, and ERβ inhibits the proliferation of breast cancer cells by repressing c-myc and cyclin A gene transcription (Paruthiyil et al., 2004). The gene discussed is ESR2; the disease is breast carcinoma.